Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Warren Buffett Stocks That Are Too Cheap to Ignore

By Josh Enomoto, InvestorPlace Contributor

Advice from the Oracle of Omaha may prove more relevant than ever now, inspiring a gander at these cheap Warren Buffett stocks.

7 Struggling IPOs to Buy for the Long-Term

By Josh Enomoto, InvestorPlace Contributor

While public market debuts present tremendous risks, the dour sentiment in this sector opens doors for speculative IPOs to buy.

7 S&P 500 Sleeper Stocks to Buy Before Wall Street Wakes Up

By Josh Enomoto, InvestorPlace Contributor

Avoid the big crowds for now and consider acquiring these sleeper S&P 500 stocks before everyone on Wall Street wakes up.

Best Stocks 2022: These 3 Factors Can Send Sonic Automotive (SAH) Stock Soaring in Q4

By Josh Enomoto, InvestorPlace Contributor

While Sonic Automotive isn’t in the lead for the top 10 best stocks ranking, SAH stock performs relatively well because of its fundamentals.

Why Is Inhibrx (INBX) Stock Soaring 45% Today?

By Josh Enomoto, InvestorPlace Contributor

Inhibrx received a vote of confidence from the Food and Drug Administration, skyrocketing the largely speculative INBX stock.

FACT Stock: What to Know as Complete Solaria Goes Public

By Josh Enomoto, InvestorPlace Contributor

Although Freedom Acquisition I Corp’s reverse merger with Complete Solaria compels, FACT stock suffers from SPACs’ poor reputation.

7 Defense Stocks That Are Too Cheap to Ignore

By Josh Enomoto, InvestorPlace Contributor

Looking for defense stocks to buy at a discount? Investors shouldn't ignore these seven too-cheap-to-ignore stock picks.

7 Nasdaq Sleeper Stocks to Buy Before Wall Street Wakes Up

By Josh Enomoto, InvestorPlace Contributor

While the underlying tech-centric exchange has suffered disproportionately, bold contrarians may consider these Nasdaq sleeper stocks to buy.

7 Under-$10 Stocks With Superior Fundamentals

By Josh Enomoto, InvestorPlace Contributor

With these intriguing ideas for stocks to buy under $10, prospective participants can possibly get more than what they paid for.

Energy Stocks CVX, XOM Rise on Potential OPEC Plus Production Cut

By Josh Enomoto, InvestorPlace Contributor

Energy stocks once again are on the radar as the oil cartel OPEC Plus intends to cut production, possibly imposing political costs.

Load More